Citius Oncology (CTOR) Stock Chart & Stock Price History $5.28 +0.07 (+1.25%) As of 01:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Citius Oncology Stock Price Performance The Citius Oncology (CTOR) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 361.22%. In the past month, the stock has increased 479.67%, reflecting recent market activity. As of the latest close, Citius Oncology traded at $5.22 with a market cap of $373.49 million and volume of 748,606 shares. Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.87%1 Month Performance+479.67%3 Month Performance+650.21%Year-To-Date Performance+361.22% CTOR Stock Chart for Thursday, July, 3, 2025 CTOR Chart by TradingView Citius Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$5.19$5.22+0.58%$5.44$4.73748,606 shs$373.49 million07/01/2025$4.35$5.19+19.31%$5.45$4.251.47 million shs$371.34 million06/30/2025$4.50$4.35-3.33%$4.86$4.061.18 million shs$311.24 million06/27/2025$3.50$4.50+28.57%$6.19$3.5211.49 million shs$321.98 million06/26/2025$2.76$3.50+26.81%$3.52$2.661.70 million shs$250.43 million06/25/2025$2.66$2.76+3.76%$2.99$2.438.38 million shs$197.48 million06/24/2025$2.50$2.66+6.40%$3.26$2.371.74 million shs$190.33 million06/23/2025$2.63$2.50-4.94%$3.07$2.371.92 million shs$178.88 million06/20/2025$1.55$2.63+69.68%$3.43$1.5720.57 million shs$188.18 million06/19/2025$1.55$1.55$1.58$1.35174,660 shs$110.91 million Get the Latest News and Ratings for CTOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$1.45$1.55+6.90%$1.58$1.35174,660 shs$110.90 million06/17/2025$1.39$1.45+4.32%$1.47$1.231.31 million shs$103.75 million06/16/2025$1.47$1.39-5.44%$1.48$1.37165,885 shs$99.46 million06/13/2025$1.47$1.47$1.50$1.45129,106 shs$105.18 million06/12/2025$1.42$1.47+3.52%$1.52$1.39338,795 shs$105.18 million06/11/2025$1.28$1.42+10.94%$1.46$1.20464,488 shs$101.60 million06/10/2025$1.23$1.28+4.07%$1.40$1.11760,721 shs$91.59 million06/09/2025$1.05$1.23+17.13%$1.31$1.0912.46 million shs$88.01 million06/06/2025$0.97$1.05+8.26%$1.09$0.97126,369 shs$75.14 million06/05/2025$0.94$0.97+3.38%$0.98$0.9537,468 shs$69.41 million06/04/2025$0.92$0.94+2.55%$0.95$0.9338,433 shs$67.14 million06/03/2025$0.89$0.92+2.80%$0.95$0.8929,834 shs$65.47 million06/02/2025$0.91$0.89-2.19%$0.90$0.8613,466 shs$63.69 million Related Companies Structure Therapeutics Stock Chart CureVac Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Aurinia Pharmaceuticals Stock Chart BGM Group Stock Chart Niagen Bioscience Stock Chart Amphastar Pharmaceuticals Stock Chart Dyne Therapeutics Stock Chart AbCellera Biologics Stock Chart Phibro Animal Health Stock Chart Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTOR) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
